切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (03) : 261 -266. doi: 10.3877/cma.j.issn.1673-5250.2023.03.003

专题论坛

早产儿疫苗预防接种及时性
周美岑, 王华(), 母得志   
  1. 四川大学华西第二医院新生儿科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2022-11-30 修回日期:2023-04-05 出版日期:2023-06-01
  • 通信作者: 王华

Vaccination timeliness in preterm infants: a review of literature

Meicen Zhou, Hua Wang(), Dezhi Mu   

  1. Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2022-11-30 Revised:2023-04-05 Published:2023-06-01
  • Corresponding author: Hua Wang
  • Supported by:
    Basic Research for Application Project of Science and Technology Department of Sichuan Province(2021YJ0171)
引用本文:

周美岑, 王华, 母得志. 早产儿疫苗预防接种及时性[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 261-266.

Meicen Zhou, Hua Wang, Dezhi Mu. Vaccination timeliness in preterm infants: a review of literature[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 261-266.

早产儿一直是全球公共卫生关注的重点人群,对其进行疫苗预防接种具有重要意义。国内外早产儿均存在疫苗接种不及时的问题,早产儿自身条件、医务系统、家庭及产妇与社会因素,均可对早产儿按时进行疫苗预防接种产生影响。笔者拟就早产儿疫苗预防接种及时性、影响因素及解决策略的最新研究现状进行阐述,旨在提高早产儿疫苗预防接种的及时性。

Preterm infants have always been the key population of global public health concern, and their vaccination is of great significance. Premature infants at home and abroad are not vaccinated in time, which is influenced by their own conditions, medical system, family, maternal and social factors. In order to improve the timeliness of premature infant vaccine vaccination, the author intends to elaborate the current research situations, influencing factors and solving strategies of timeliness of premature infants vaccine vaccination.

[1]
Rayment-Jones H, Dalrymple K, Harris J, et al. Project20: does continuity of care and community-based antenatal care improve maternal and neonatal birth outcomes for women with social risk factors? A prospective, observational study[J]. PLoS One, 2021, 16(5): e0250947. DOI: 10.1371/journal.pone.0250947.
[2]
Deng K, Liang J, Mu Y, et al. Preterm births in China between 2012 and 2018: an observational study of more than 9 million women[J]. Lancet Glob Health, 2021, 9(9): e1226-e1241. DOI: 10.1016/S2214-109X(21)00298-9.
[3]
Nassir KF, Al-Saddi YI, Abbas HM, et al. Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis[J]. Indian J Pharmacol, 2021, 53(5): 364-370. DOI: 10.4103/ijp.ijp_881_20.
[4]
Soans S, Mihalyi A, Berlaimont V, et al. Vaccination in preterm and low birth weight infants in India[J]. Hum Vaccin Immunother, 2022, 18(1): 1-12. DOI: 10.1080/21645515.2020.1866950.
[5]
Tozzi AE, Piga S, Corchia C, et al. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project[J]. Vaccine, 2014, 32(7): 793-799. DOI: 10.1016/j.vaccine.2013.12.044.
[6]
Sioriki AA, Gkentzi D, Papadimitriou E, et al. Vaccinations in infants born preterm: an update[J]. Curr Pediatr Rev, 2020, 16(2): 148-155. DOI: 10.2174/1573396316666200116094459.
[7]
Guarnieri V, Giovannini M, Lodi L, et al. Severe pertussis disease in a paediatric population: the role of age, vaccination status and prematurity[J]. Acta Paediatr, 2022, 111(9): 1781-1787. DOI: 10.1111/apa.16436.
[8]
Bary-Weisberg D, Stein-Zamir C. Vaccination timeliness and completeness among preterm and low birthweight infants: a national cohort study[J]. Hum Vaccin Immunother, 2021, 17(6): 1666-1674. DOI: 10.1080/21645515.2020.1840255.
[9]
马超,安志杰,曾玫,等.《国家免疫规划疫苗儿童免疫程序及说明(2021年版)》要点解析[J]. 中国疫苗和免疫2021, 27(3): 235-241. DOI: 10.19914/j.cjvi.2021041.
[10]
Cho HK, Park SE, Kim YJ, et al. Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants[J]. Clin Exp Pediatr, 2021, 64(12): 602-607. DOI: 10.3345/cep.2021.00507.
[11]
Badurdeen S, Marshall A, Daish H, et al. Safety and immunogenicity of early bacillus Calmette-Guérin vaccination in infants who are preterm and/or have low birth weights: a systematic review and Meta-analysis[J]. JAMA Pediatr, 2019, 173(1): 75-85. DOI: 10.1001/jamapediatrics.2018.4038.
[12]
宋渝丹,黎祺,黄勇,等. 中国特殊健康状态儿童疫苗接种研究进展[J]. 中国疫苗和免疫2022, 28(5): 595-600. DOI: 10.19914/j.CJVI.2022114.
[13]
Immunization in preterm and low birth weight infants[M]// Committee on Infectious Diseases, American Academy of Pediatrics; Kimberlin DW; Barnett ED; et al. Red book: 2021–2024 report of the committee on infectious diseases (32nd edition). American Academy of Pediatrics, 2021: 67-69.

URL    
[14]
Walker EJ, MacDonald NE, Islam N, et al. Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: a systematic review[J]. Vaccine, 2019, 37(13): 1725-1735. DOI: 10.1016/j.vaccine.2019.02.031.
[15]
黄丽芳,周勇,吴瑞红,等. 福建省2017—2019年出生早产儿和低出生体重儿首剂乙型肝炎疫苗接种率和影响因素调查[J]. 中国疫苗和免疫2021, 27(3): 292-296. DOI: 10.19914/j.CJVI.2021054.
[16]
Qin W, Wang Y, Zhang X, et al. A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: Time to close the policy-practice gap[J]. Hum Vaccin Immunother, 2022, 18(7): 2155390. DOI: 10.1080/21645515.2022.2155390.
[17]
Jacobson EN, Hofstetter AM, Englund JA, et al. Early childhood vaccination status of preterm infants[J]. Pediatrics, 2019, 144(3): e20183520. DOI: 10.1542/peds.2018-3520.
[18]
Berbers GAM, Rouers EDM, Sanders EAM, et al. Timeliness of immunisations in preterm infants in the Netherlands[J]. Vaccine, 2019, 37(39): 5862-5867. DOI: 10.1016/j.vaccine.2019.08.006.
[19]
冯艳,吴长玉,王丽丽. 2015—2019年产科新生儿乙肝疫苗接种现状及对策探讨[J]. 临床医药文献电子杂志2020, 7(89): 167, 173.
[20]
古吉燕,王念蓉,何春燕,等. 0~6个月龄早产儿免疫规划疫苗接种情况分析[J]. 中国初级卫生保健2022, 36(3): 63-66, 71. DOI: 10.3969/j.issn.1001-568X.2022.03.0019.
[21]
李新海,温庆良,阮妹娇,等. 深圳市龙山社区儿童卡介苗接种率和及时接种率调查[J].预防医学情报杂志2021, 37(2): 265-270.
[22]
Choudhary TS, Reddy NS, Apte A, et al. Delayed vaccination and its predictors among children under 2 years in India: insights from the national family health survey-4[J]. Vaccine, 2019, 37(17): 2331-2339. DOI: 10.1016/j.vaccine.2019.03.039.
[23]
黄焕辉,韦日强. 2015—2018年河池市宜州区新生儿首针乙肝疫苗接种情况分析[J]. 中国当代医药2020, 27(13): 177-179..DOI: 10.3969/j.issn.1674-4721.2020.13.052.
[24]
师燕,朱一凡,刘海洋. 2018~2020年我院出生的新生儿乙肝疫苗首针接种情况的调查及影响因素分析[J]. 黑龙江医药科学2022, 45(5): 140-141, 143. DOI: 10.3969/j.issn.1008-0104.2022.05.060.
[25]
Gopal SH, Edwards KM, Creech B, et al. Variability in immunization practices for preterm infants[J]. Am J Perinatol, 2018, 35(14): 1394-1398. DOI: 10.1055/s-0038-1660453.
[26]
古吉燕,王念蓉,刘霞,等. 重庆市1 129名特殊健康状态儿童首针乙肝疫苗卡介苗迟种原因分析[J]. 公共卫生与预防医学2022, 33(3): 33-36. DOI: 10.3969/j.issn.1006-2483.2022.03.007.
[27]
雷妍. 城区孕妇乙型肝炎表面抗原携带率筛查和新生儿首剂乙肝疫苗及时接种保健工作现状分析[J]. 双足与保健2017, 26(20): 38-39. DOI: 10.19589/j.cnki.issn1004-6569.2017.20.038.
[28]
Nakatudde I, Rujumba J, Musoke P, et al. Vaccination timeliness and associated factors among preterm infants at a tertiary hospital in Uganda[J]. PLoS One, 2020, 14(9): e0221902. DOI: 10.1371/journal.pone.0221902.
[29]
王运媛,吴惠君,陈娇,等. 早产儿家长对卡介苗等免疫接种意愿状况及其影响因素分析[J]. 医学动物防制2020, 36(11): 1081-1084. DOI: 10.7629/yxdwfz202011016.
[30]
Di Mauro A, Di Mauro F, Greco C, et al. In-hospital and web-based intervention to counteract vaccine hesitancy in very preterm infants′ families: a NICU experience[J]. Ital J Pediatr, 2021, 47(1): 190. DOI: 10.1186/s13052-021-01129-x.
[31]
Chiappini E, Petrolini C, Caffarelli C, et al. Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of Neonatology[J]. Ital J Pediatr, 2019, 45(1): 145. DOI: 10.1186/s13052-019-0742-7.
[32]
Laforgia N, Di Mauro A, Bianchi FP, et al. Are pre-terms born timely and right immunized? Results of an Italian cohort study[J]. Hum Vaccin Immunother, 2018, 14(6): 1398-1402. DOI: 10.1080/21645515.2018.1428509.
[1] 唐蜜, 蔡江晖, 罗尔丹, 郭文玫, 熊丽玲, 林永红, 邢莎莎, 杨霄. 多肽疫苗治疗乳腺癌的临床研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 309-313.
[2] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[3] 胡诤贇, 史建伟, 申建伟, 王冰, 蒋春苗, 刘冲. 基于机器学习鉴定早产儿支气管肺发育不良的关键基因[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 446-454.
[4] 熊风, 林辉煌, 陈晓波. 铥激光在泌尿外科中的临床应用及研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 533-536.
[5] 彭永辉, 张文杰, 李炳根, 聂向阳, 吴凯, 杨六成. 单孔双针疝囊高位结扎术在儿童巨大腹股沟疝的临床应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 566-569.
[6] 刘骏, 朱霁, 殷骏. 右美托咪定对腹股沟疝手术麻醉效果及安全性的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 570-573.
[7] 王红敏, 谢云波, 王彦虎, 王福生. 间充质干细胞治疗新冠病毒感染的临床研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 247-256.
[8] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[9] 程庆砾. 新冠病毒感染与肾脏[J]. 中华肾病研究电子杂志, 2023, 12(04): 240-240.
[10] 娜荷雅, 朱丹. 红光疗法在儿童近视眼防控中的研究进展[J]. 中华眼科医学杂志(电子版), 2023, 13(04): 252-256.
[11] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[12] 陈婷婷, 江学良, 余佳丽, 柯剑林. 干细胞治疗炎症性肠病的安全性[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 193-198.
[13] 朴成林, 蓝炘, 司振铎, 冯健, 安峰铎, 李强, 谈明坤, 赵娜, 冷建军. 局部晚期右半结肠癌行结肠癌根治联合胰十二指肠切除术疗效分析:附5例报告[J]. 中华临床医师杂志(电子版), 2023, 17(06): 666-670.
[14] 曹文玺, 陈箫, 竺来法, 周永平. 尼妥珠单抗联合白蛋白结合型紫杉醇治疗胰腺癌的有效性及安全性分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 409-413.
[15] 梁君, 褚晨宇, 孙凤艳, 袁仪浪, 周曦, 王卫东. 胸壁完全植入式静脉输液港术中隧道针逆向穿刺的可行性和安全性[J]. 中华介入放射学电子杂志, 2023, 11(04): 310-313.
阅读次数
全文


摘要